Venmax Drugs and Pharmaceuticals has informed that in order to comply with the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 15(2)(a) of Chapter IV of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Paid-up Share Capital of the Company is not exceeding Rs 10 Crores and the Networth is less than Rs 25 Crores, as on the last day of the previous Financial Year March 31, 2023. In line with the above, the Company is not required to submit the Report on Corporate Governance for the Quarter ended September 30, 2023.
The above information is a part of company’s filings submitted to BSE.
